Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education
Clinical trial update for GYN-AIDE, an AI-driven education/navigation tool in gynecologic oncology, focusing on endometrial cancer; status n…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence [NA]
Clinical trial update for a study on social interventions to support individuals undergoing treatment for endometrial cancer and its recurre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial [NA]
This ClinicalTrials.gov entry describes a non-inferiority randomized trial comparing sentinel lymph node mapping to comprehensive lymphadene…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]
TORL Biotherapeutics announced a first-in-human Phase 1 trial of TORL-1-23 for advanced cancers. The study is currently recruiting and inclu…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the levonorgestrel-releasing intrauterine system with or without everolimus to treat atypical endomet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer
A clinical trial update notes that Endoscopic Suture Gastroplasty (ESG) is being studied as a treatment approach for obese patients with End…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial evaluating the effectiveness of combining DKN-01 (a DKK1 inhibitor) with pembrolizumab in advanced or recurrent endom…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]
A Phase II, two-arm trial evaluating everolimus and letrozole with or without ribociclib (Lee011) in patients with advanced or recurrent end…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: ALPINE: Maintenance Letrozole/Abemaciclib [Phase 2]
Phase 2 trial update for ALPINE evaluating maintenance letrozole plus abemaciclib in endometrial cancer and recurrent endometrial cancer; st…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial is evaluating the combination of lenvatinib, pembrolizumab, and paclitaxel for recurrent endometrial, ovarian, fallopian …
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer [Phase 1]
Phase 1 clinical trial evaluating frontline immunotherapy combined with radiation and chemotherapy in high-risk endometrial cancer is active…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
A recruiting clinical trial from University Hospital Tuebingen is studying immunotherapy-related CRP kinetics in metastatic gynecological ca…
-
CLINICAL_TRIALS other · 2026-02-09Clinical Trial Update: A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of IDE161, a PARG inhibitor, is recruiting in patients with several solid tumor types including breast, ovarian, and various l…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Endometrial Cell Collection With the PadKit [NA]
This clinical trial update indicates that the Endometrial Cell Collection with the PadKit study (NCT06464107), sponsored by Hackensack Merid…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: 3D Printed Custom Applicators for HDR BT (DISCO) [NA]
This clinical trial update notes that recruitment is ongoing for a study using 3D-printed custom applicators for high-dose-rate brachytherap…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for MGC026 in participants with advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer [NA]
Withdrawn clinical trial evaluating a virtual mental health intervention for fear of progression in women with high-risk or stage III-IV gyn…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer [Phase 3]
Phase 3 clinical trial comparing trastuzumab deruxtecan to standard chemotherapy in HER2-expressing endometrial cancer is currently recruiti…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry
This clinical registry study from Tata Memorial Hospital examines how molecular, pathological, and clinical features may influence adjuvant …
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer [EARLY_Phase 1]
An early-phase study evaluating short-course radiation therapy combined with chemotherapy in people with endometrial cancer is currently rec…
-
CLINICAL_TRIALS withdrawal · 2026-02-03Clinical Trial Update: Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer [NA]
A clinical trial evaluating quality of life during radiotherapy for recurrent head and neck cancer has been withdrawn; the study also listed…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery [Phase 2]
Phase 2 clinical trial evaluating the combination of radiation therapy with dostarlimab (TSR-042) in patients with endometrial cancer after …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer
This clinical trial update outlines a prospective cohort study evaluating minimal residual disease testing to detect early recurrence in end…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer
This clinical trial update examines how dose and storage conditions of indocyanine green affect the efficacy and cost of sentinel lymph node…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors [Phase 1, Phase 2]
This entry describes a Phase 1/2 study evaluating the safety, pharmacokinetics, and preliminary effectiveness of GSK4418959 in participants …